The Guardian
Email YouTube Facebook Instagram Twitter

GSK partners PAN on better medicare for African child

Related


Leading drug maker, GSK Pharmaceuticals Limited, and the Paediatric Association of Nigeria (PAN) have struck a partnership geared at broadening access to medication by the African child.

Consequently, the pharmaceutical firm partnered with PAN at the recent Union of African Paediatrics Societies Association (UNAPSA)-PAN Conference 2018 in Abuja.

According to the Medical Director, GSK Pharma, Dr. Omolaja Odunuga, in a statement, the move is consistent with the company’s commitment towards creating awareness on prevention of childhood diseases through vaccination and the direct link of antimicrobial resistance (AMR) to inappropriate use of antibiotics.

The conference, which is the largest gathering of paediatricians on the continent, was put together by the PAN and UNAPSA Association with over 1,000 delegates from the pharmaceutical and health sectors in deliberating on the theme, Impact of deprivations and inequity on the African child.

Dr. Goke Ewedairo and Mr. Olumide Aniyikaiye threw more light on the pharmaceutical company’s campaign against AMR.

Specifically, Odunuga noted that the firm had put in place measures that allow more patients get quality medication. He listed some of them to include provision of classic and access portfolios.

He said: “Putting patients first in everything we do is paramount. For GSK, how we do things is just as important as what we do. Our values-based culture is designed to ensure we put the interest of patients and customers first.”


In this article:
GSKOmolaja OdunugaUNAPSA

No Comments yet